Abstract
The present study was planned to review the pathophysiology of uterine myomas and
emphasize the principles of logical management on the basis of literature review and
synthesis of the author's experience. The growth of uterine myomas, the most common
solid pelvic tumors in women, is related to genetic predisposition, hormonal influences
and growth factors. The treatment options include pharmacologic, surgical and radiographic
interventions. Most asymptomatic myomas can be followed serially for progressive growth
or development of symptoms. The various diagnostic and therapeutic advancements available
today permit higher management flexibility with safe options, which must be tailored
to the individual patients requirement.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Obstetrics and Gynecology and Reproductive BiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Uterine myomas: an overview of development, clinical features, and management.Obstet Gynecol. 2004; 104: 393-406
- Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells.Fertil Steril. 2006; 86: 1736-1743
- The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.Am J Obstet Gynecol. 2008; 198 (168e1–9)
- What are the implications of myomas on fertility? A need for a debate?.Hum Reprod. 2002; 17: 1424-1430
- Myomas and assisted reproductive technologies: when and how to act?.Obstet Gynecol Clin North Am. 2006; 33: 145-152
- Reproductive outcome before and after laparoscopic or abdominal myomectomy for subserous or intramural myomas.Eur J Obstet Gynaecol Reprod Biol. 2003; 110: 215-219
- Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.Obstet Gynecol. 1994; 83: 414-418
- The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis external and myoma uteri.Cancer Epidemiol. 2004; 28: 94-98
- GnRH analogues in the treatment of uterine fibroids.Hum Reprod. 1996; 11: 33-41
- Leiomyoma pseudocapsule after presurgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes.Eur J Obstet Gynecol Reprod Biol. 2009; 144: 44-47
- GnRH agonists before surgery for uterine biomyomas: a review.J Reprod Med. 1996; 41: 415-421
- Danazol administration after gonadotropin-releasing hormone analogue reduces rebound of uterine myomas.Hum Reprod. 1997; 12: 357-360
- Low dose mifepristone for uterine leiomyomata.Obstet Gynecol. 2003; 101: 243-250
- The use of levonorgestrel-IUD in the treatment of uterine myoma in Thai women.J Med Assoc Thai. 2006; 89: S147-S151
- The management of uterine leiomyomas.J Obstet Gynecol. 2003; 25: 395-418
- Urinary tract injuries after hysterectomy.Obstet Gynecol. 1998; 92: 113-118
- Outcomes after total versus subtotal abdominal hysterectomy.N Engl J Med. 2002; 347: 1318-1325
- Hysterectomy in the United States, 1988–1990.Obstet Gynecol. 1994; 83: 549-555
- Laparoscopic versus open myomectomy—a meta-analysis of randomized controlled trials.Eur J Obstet Gynecol Reprod Biol. 2009; 145: 14-21
- Interventions to reduce hemorrhage during myomectomy for fibroids.Cochrane Database Syst Rev. 2009; (Art No.: CD005355)https://doi.org/10.1002/14651858.CD005355.pub
- Isthmic uterine fibroids: the dynamics of growth.Arch Gynecol Obstet. 2009; 280: 309-312
- Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas.Am J Obstet Gynecol. 2000; 183: 1448-1455
- Role of vaginal sonography and hysterosonography in endoscopic treatment of uterine myomas.Fertil Steril. 2000; 73: 197-204
- Reproductive outcome after laparoscopic myomectomy for intramural myomas in infertile women with or without associated infertility factors.Reprod Med Biol. 2008; 5: 31-35
- Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry.Obstet Gynecol. 2008; 111: 22-33
- Uterine artery embolization for symptomatic uterine myomas.Fertil Steril. 2000; 74: 855-869
- Pregnancy after embolization of uterine myoma: report of 12 cases.Fertil Steril. 2000; 73: 1241-1243
- Focused ultrasound for treatment of uterine myoma: from experimental model to clinical practice.Srp Arh Celok Lek. 2008; 136: 193-195
- Reduction by 98% in uterine myoma volume associated with significant symptom relief after peripheral treatment with magnetic resonance imaging-guided focused ultrasound surgery.J Minim Invasive Gynecol. 2009; 16: 501-503
- Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-imaging predictors of success.Radiologia. 2008; 249: 187-194
- Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images.Am J Obstet Gynecol. 2007; 196 (184.e1–6)
- Myoma coagulation (myolysis).Obstet Gynecol Clin North Am. 2000; 27: 421-430
- Interventional magnetic resonance imaging cryotherapy of uterine fibroid tumors: preliminary observation.Am J Obstet Gynecol. 2002; 186: 1183-1187
Article info
Publication history
Published online: June 07, 2010
Accepted:
May 24,
2010
Received in revised form:
April 17,
2010
Received:
October 29,
2009
Identification
Copyright
© 2010 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.
